OS Leadership Wednesday, September 9, 2026 0.00 Neutral

OS Therapies approves amended and restated incentive plan

OS Therapies Inc. filed an Amended and Restated 2023 Incentive Compensation Plan with the SEC, outlining terms for stock-based awards to employees and executives.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day